Clinical aspects of melatonin.

Area of Science:

• Neuroscience
• Endocrinology
• Chronobiology

Background:

• Melatonin is a hormone primarily produced by the pineal gland, with its secretion following a distinct circadian rhythm.
• Disruptions to this rhythm, caused by factors like light exposure at night or transmeridian travel, can lead to sleep disturbances such as jet lag and reduced sleep quality.

Purpose of the Study:

• To explore the multifaceted roles of melatonin beyond its function in regulating circadian rhythms.
• To investigate melatonin's potential as a therapeutic agent for various medical conditions, including oxidative stress-related disorders and hypertension.

Main Methods:

• The study reviews existing literature on melatonin production, its physiological effects, and its therapeutic applications.
• It examines evidence from experimental models and clinical observations regarding melatonin's antioxidant and protective properties.

Main Results:

• Melatonin administration effectively improves sleep inefficiency and jet lag symptoms caused by circadian rhythm disruption.
• Melatonin demonstrates significant free radical scavenging and antioxidant capabilities, reducing oxidative damage in models of neurological injury (stroke, Parkinson's, Alzheimer's) and experimental cataractogenesis.
• Melatonin and its metabolites offer protection against ionizing radiation and may serve as a potential treatment for hypertension.

Conclusions:

• Melatonin plays a crucial role in regulating circadian rhythms and sleep.
• Its potent antioxidant and protective properties suggest broad therapeutic potential in managing conditions associated with oxidative stress and radiation exposure.
• The high safety profile and efficacy of melatonin make it a promising candidate for clinical applications in various medical fields.